Global Peptide Vaccine Market Sales Revenue Clinical Trials Pipeline Report

Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to identify self from non-self which is artificially provided by vaccines. When foreign entity penetrates into the body, defence mechanism already triggered by vaccines gets activated to protect from spread of pathogen.

Download Report:

https://www.kuickresearch.com/report-Global-Peptide-Vaccine-Market-&-Pipeline-Insight.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Global Peptide Vaccine Market & Pipeline Insight" Table of Contents

1. Introduction to Peptide Vaccine

2. Mechanism of Peptide Vaccine

3. Global Peptide Vaccine Market Overview
3.1 Current Market Scenario
3.2 Peptide Vaccine Clinical Pipeline Overview

4. Global Peptide Vaccine Market Dynamics
4.1 Market Drivers
4.2 Challenges

5. Global Peptide Vaccine Market Future Prospects

6. Global Peptide Vaccine Pipeline by Phase, Indication, Company & Country
6.1 Research
6.2 Preclinical
6.3 Clinical
6.4 Phase-I
6.5 Phase-I/II
6.6 Phase-II
6.7 Phase-II/III
6.8 Phase-III

7. Discontinued & No Development Reported in Peptide Vaccine Clinical Pipeline
7.1 No Development Reported
7.2 Discontinued

8. Competitive Landscape
8.1 Apitope Technology
8.2 BiondVax Pharmaceuticals Ltd
8.3 Circassia
8.4 Eli Lily
8.5 Galena Biopharmaceuticals
8.6 GlaxoSmithKline
8.7 Hyperion Therapeutics
8.8 ImmunoCellular Therapeutics
8.9 Merck
8.10 OncoTherapy Science

Figure 1-1: Different Types of Vaccines
Figure 1-2: Criteria for Ideal Peptide Vaccine
Figure 1-3: Peptide Vaccines Delivery System
Figure 2-1: Mechanism of Peptide Vaccines
Figure 2-2: Mechanism of Live Vaccines
Figure 2-3: Mechanism of Toxoid & Inactivated Vaccine
Figure 2-4: Mode of Action of Peptide Cancer Vaccines
Figure 3-1: Global Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-2: Global Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 3-3: No Development Reported in Global Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-4: No Development Reported in Global Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 3-5: Discontinued Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-6: Discontinued Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 4-1: Global Peptide Vaccine Market Drivers
Figure 4-2: Global Peptide Vaccine Market Challenges

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.